2024-06-01 · Addpharma Inc. · original addpharma.co.kr ↗
애드파마의 역류성 식도염 개량신약 AD-214가 식품의약품안전처 품목허가를 획득했다.
The release as fetched from its publisher. addpharma.co.kr ↗